Robert Nelsen, Director, 10% Owner at Sana Biotechnology, Inc. (SANA), bought 1,454,546 shares at $5.50 ($8.0M) on 2024-02-08, disclosed to the SEC on 2024-02-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.50 | 363,637 | $2.0M | 25.0% |
| 2 | $5.50 | 363,637 | $2.0M | 25.0% |
| 3 | $5.50 | 727,272 | $4.0M | 50.0% |
| Total | $5.50 avg | 1,454,546 | $8.0M | 100% |
| Filing → |
| NMRA | BUY | 2023-09-29 | $2.1M | — | Filing → |
| NMRA | BUY | 2023-09-27 | $1.0M | — | Filing → |
| NMRA | BUY | 2023-09-25 | $1.8M | — | Filing → |